Indexing
All Issues
Submission
Author Guidelines
Reviewers
Editorial Members
Publication Fee
Vol.4 , No. 6, Publication Date: Dec. 7, 2017, Page: 74-78
 and Ebola virus disease (2014), Japan has tried to strengthen research and development (R&D), focusing on emerging/reemerging infectious diseases through “The Healthcare Policy”. In order to contribute to such a national strategy, the Science and Technology Foresight Center of the National Institute of Science and Technology Policy conducted an expert questionnaire survey on the direction of R&D for emerging/reemerging infectious disease control in September 2014. The survey revealed that among experts, R&D for emerging/reemerging infectious disease control is considered to be very important but vulnerable to tough international competition. Moreover, topics that should receive priority included those related to HIV/AIDS, drug-resistant infections, and influenza. Finally, it was suggested that recent information technology (IT) development such as big data analytics had potential for being applied to the emerging/reemerging infectious disease field. Although the survey has several limitations, such results may contribute to designing and supporting a setting of concrete R&D programs in Japan and other countries.&picture=http://www.aascit.org/aascit/decorators/img/journal/972.jpg)
| [1] | Hiromi Takahashi-Omoe, Science and Technology Foresight Center, National Institute of Science and Technology Policy, Tokyo, Japan. |
Since long, Japan has addressed infectious disease control through regulatory and scientific frameworks. Due partly to the outbreaks of H1N1 pandemic (2009) and Ebola virus disease (2014), Japan has tried to strengthen research and development (R&D), focusing on emerging/reemerging infectious diseases through “The Healthcare Policy”. In order to contribute to such a national strategy, the Science and Technology Foresight Center of the National Institute of Science and Technology Policy conducted an expert questionnaire survey on the direction of R&D for emerging/reemerging infectious disease control in September 2014. The survey revealed that among experts, R&D for emerging/reemerging infectious disease control is considered to be very important but vulnerable to tough international competition. Moreover, topics that should receive priority included those related to HIV/AIDS, drug-resistant infections, and influenza. Finally, it was suggested that recent information technology (IT) development such as big data analytics had potential for being applied to the emerging/reemerging infectious disease field. Although the survey has several limitations, such results may contribute to designing and supporting a setting of concrete R&D programs in Japan and other countries.
Keywords
Infectious Disease, Research and Development, Expert Questionnaire
Reference
| [01] | Brown C. Emerging zoonoses and pathogens of public health significance–an overview. Rev sci tech Off Int Epiz 2004; 23: 435-42. |
| [02] | Woodworth BL, Atkinson CT, LaPointe DA, et al. Host population persistence in the face of introduced vector-borne diseases: Hawaii amakihi and avian malaria. Proc Natl Acad Sci USA 2005; 102: 1531-6. |
| [03] | Takahashi-Omoe H, Omoe K. Regulatory and scientific frameworks for zoonosis control in Japan-contributing to international health regulations (2005). Rev Sci Tech. 2009; 28: 957-73. |
| [04] | Japan Agency for Medical Research and Development. Japan initiative for global research network on infectious diseases (J-GRID) Available at. http://www.amed.go.jp/en/program/list/01/06/023.html (accessed on July 11, 2017). |
| [05] | Cabinet of Japan. The Healthcare Policy. Available at. http://www.kantei.go.jp/jp/singi/kenkouiryou/en/pdf/policy.pdf (accessed on July 11, 2017). |
| [06] | Japan Agency for Medical Research and Development. Available at. http://www.amed.go.jp/en/ (accessed on July 11, 2017). |
| [07] | Cabinet Secretariat. Overview of the Healthcare Policy. Available at. http://www.kantei.go.jp/jp/singi/kenkouiryou/en/pdf/doc2.pdf (accessed on July 11, 2017). |
| [08] | Gallagher M, Bradshaw C, Nattress H. Policy priorities in diabetes care: a Delphi study. Qual Health Care 1996; 5: 3-8. |
| [09] | National Institute of Science and Technology Policy. Science and technology foresight. Available at. http://www.nistep.go.jp/en/?page_id=56 (accessed on July 11, 2017). |
| [10] | AIDS Surveillance Committee, the Ministry of Health, Labour and Welfare. 2013 report of AIDS surveillance. Available at. http://api-net.jfap.or.jp/status/2013/13nenpo/nenpo_menu.htm (in Japanese, accessed on July 11, 2017). |
| [11] | G-Science. Drug Resistance in Infectious Agents–A Global Threat to Humanity. 2013. Available at. http://www.scj.go.jp/ja/info/kohyo/pdf/kohyo-22-gs2013-2.pdf (accessed on July 11, 2017). |
| [12] | Cabinet Secretariat. National Action Plan for Pandemic Influenza and New Infectious Diseases. 2013. Available at. http://www.cas.go.jp/jp/seisaku/ful/keikaku/pdf/national%20action%20plan.pdf (accessed on July 11, 2017). |
